Linking Cardiovascular Risk With Estradiol Level in Men.


Journal

Kardiologiia
ISSN: 0022-9040
Titre abrégé: Kardiologiia
Pays: Russia (Federation)
ID NLM: 0376351

Informations de publication

Date de publication:
30 Sep 2023
Historique:
received: 02 03 2023
accepted: 17 03 2023
medline: 1 11 2023
pubmed: 10 10 2023
entrez: 10 10 2023
Statut: epublish

Résumé

Aim      To study the relationship between the cardiovascular risk and the level of estradiol in men of young and middle age. The main group included 71 patients with newly diagnosed hyperestrogenia (HE) (serum estradiol >41.2 pg/ ml). Using pseudorandomization, 68 men with normal estradiol level and age- and body weight index (BWI)-matched with the main group were included into the control group. Anthropometric data, bioimpedance variables, blood pressure (BP), and concentrations of estradiol, testosterone, glucose, and total cholesterol were analyzed in both groups.Results Patients of the main and control groups did not differ in age, BWI, and smoking status. Testosterone concentration was 10.18 nmol/l in the HE group and 12.18 nmol /l in the control group (p=0.006). Systolic BP was 142.0 mm Hg in the HE group and 135.2 mm Hg in the control group (p=0.011); diastolic BP was 90.3 mm Hg in the HE group and 86.2 mm Hg in the control group (p=0.008). Total cholesterol was 5.87 mmol/l in the HE group and 5.33 mmol/l in the control group (p=0.023). Blood glucose did not differ between the groups. The presence of HE in men 2.11 times (р=0.038) increased the probability of arterial hypertension. The intergroup difference by the SCORE scale did not reach statistical significance (р=0.172). BWI, waist and hip circumferences, and bioimpedance body composition parameters did not differ between the groups.Conclusion      In the studied cohort of young and middle-aged men, HE was an independent predictor for the presence of arterial hypertension. There were no significant intergroup differences in the total risk of cardiovascular diseases calculated with the SCORE scale.

Identifiants

pubmed: 37815135
doi: 10.18087/cardio.2023.9.n2450
doi:

Substances chimiques

Testosterone 3XMK78S47O
Estradiol 4TI98Z838E
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article

Langues

rus eng

Sous-ensembles de citation

IM

Pagination

14-19

Auteurs

Ia A Orlova (IA)

Medical Research and Educational Center, Lomonosov Moscow State University, Moscow; School of Fundamental Medicine, Lomonosov Moscow State University, Moscow.

E D Sorokin (ED)

School of Fundamental Medicine, Lomonosov Moscow State University, Moscow.

Z Sh Pavlova (ZS)

Medical Research and Educational Center, Lomonosov Moscow State University, Moscow.

A G Plisyuk (AG)

Medical Research and Educational Center, Lomonosov Moscow State University, Moscow; School of Fundamental Medicine, Lomonosov Moscow State University, Moscow.

A A Kamalov (AA)

Medical Research and Educational Center, Lomonosov Moscow State University, Moscow; School of Fundamental Medicine, Lomonosov Moscow State University, Moscow.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH